Abu-Raddad, L. J., Chemaitelly, H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., . . . Bertollini, R. (2021). Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med.
Stile di citazione ChicagoAbu-Raddad, Laith J., et al. "Pfizer-BioNTech MRNA BNT162b2 Covid-19 Vaccine Protection against Variants of Concern After One Versus Two Doses." J Travel Med 2021.
Citazione MLAAbu-Raddad, Laith J., et al. "Pfizer-BioNTech MRNA BNT162b2 Covid-19 Vaccine Protection against Variants of Concern After One Versus Two Doses." J Travel Med 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.